Felipe Prosper

Hematology and Cell Therapy Area, Clínica Universidad de Navarra and Instituto de Investigación Sanitaria de Navarra (IdiSNA)

Affiliated withClínica Universidad de Navarra and Instituto de Investigación Sanitaria de Navarra (IdiSNA)Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) CB16/12/00489 CIMA Universidad de Navarra

Research Area

Bioengineering

Biography

Felipe Prosper has not added Biography.
If you are Felipe Prosper and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2025

Other Publications

Article	Year
In-silico gene essentiality analysis of polyamine biosynthesis reveals APRT as a potential target in cancer. Scientific reports\| PubMed ID: 29084986	2017
Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: long-term follow up of a mul... Journal of translational medicine\| PubMed ID: 30064455	2018
Allogeneic Mesenchymal Stem Cells and Biomaterials: The Perfect Match for Cardiac Repair? International journal of molecular sciences\| PubMed ID: 30347686	2018
Epigenomic profiling of myelofibrosis reveals widespread DNA methylation changes in enhancer elements and as a potential tumor suppressor gene that is epigenetically regulated. Haematologica\| PubMed ID: 30655376	2019
Long non-coding RNAs discriminate the stages and gene regulatory states of human humoral immune response. Nature communications\| PubMed ID: 30778059	2019
Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression. Nature medicine\| PubMed ID: 31270502	2019
DNA Methylation of Enhancer Elements in Myeloid Neoplasms: Think Outside the Promoters? Cancers\| PubMed ID: 31554341	2019
Generation of an induced pluripotent stem cell line (CIMAi001-A) from a compound heterozygous Primary Hyperoxaluria Type I (PH1) patient carrying p.G170R and p.R122* mutations in the AGXT ge... Stem cell research\| PubMed ID: 31715429	2019
Phase II multicenter randomized controlled clinical trial on the efficacy of intra-articular injection of autologous bone marrow mesenchymal stem cells with platelet rich plasma for the trea... Journal of translational medicine\| PubMed ID: 32948200	2020
Delivery of cardiovascular progenitors with biomimetic microcarriers reduces adverse ventricular remodeling in a rat model of chronic myocardial infarction. Acta biomaterialia\| PubMed ID: 33716175	2021
Isolation methods of large and small extracellular vesicles derived from cardiovascular progenitors: A comparative study. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V\| PubMed ID: 34968647	2022
G9a inhibition by CM-272: Developing a novel anti-tumoral strategy for castration-resistant prostate cancer using 2D and 3D in vitro models. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie\| PubMed ID: 35483199	2022
The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromes. Nature communications\| PubMed ID: 36494342	2022
Revealing cell populations catching the early stages of human embryo development in naive pluripotent stem cell cultures. Stem cell reports\| PubMed ID: 36563688	2023
Gene therapy restores the transcriptional program of hematopoietic stem cells in Fanconi anemia. Haematologica\| PubMed ID: 37021532	2023
Experimentally-guided in silico design of engineered heart tissues to improve cardiac electrical function after myocardial infarction. Computers in biology and medicine\| PubMed ID: 38335818	2024
Single-cell transcriptional profile of CD34+ hematopoietic progenitor cells from del(5q) myelodysplastic syndromes and impact of lenalidomide. Nature communications\| PubMed ID: 38902243	2024
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia. Nature communications\| PubMed ID: 38956053	2024
BET inhibitors downregulate the expression of the essential lncRNA in multiple myeloma through regulation of the transcription factor FLI1. Haematologica\| PubMed ID: 39323408	2025
An automated network-based tool to search for metabolic vulnerabilities in cancer. Nature communications\| PubMed ID: 39394196	2024